Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Spire Healthcare sees low-end profit amid NHS commissioning slowdown

Wed, 03rd Dec 2025 10:06

(Alliance News) - Spire Healthcare Group PLC on Wednesday warned the recent slowdown in NHS commissioning activity would dent full-year profits.

In response, shares in the London-based private healthcare provider slumped 14% to 191.80 pence each in London on Wednesday morning.

Spire said trading has been "positive" since interim results in July, with revenue growth of 3.6% on-year in the four-months from July to October.

But while self-pay trends have continued to improve, this has not been sufficient to offset the recent slowdown in NHS commissioning activity, due to Integrated Care Board budgetary restrictions.

As a result, the firm expects full-year adjusted group earnings before interest, tax, depreciation and amortisation to be around the bottom end of the GBP270 million to GBP285 million guidance range.

For financial 2026, Spire expects adjusted Ebitda to be "broadly in line or slightly ahead of 2025."

In 2024, Spire reported adjusted Ebitda of GBP260 million, up 11% from GBP234.0 million in 2023.

"Looking further ahead, we would naturally expect this market environment to lead to further growth in private patient volumes and we remain confident in the medium-term outlook," the firm added.

Spire said it continues to evaluate actions that could "drive long-term sustainable shareholder value".

The strategic review, which was announced in September, "remains ongoing".

Spire said it has started talks with "a number of parties in relation to a range of potential options", which may include a potential sale of the company, value generation from the Hospital property estate and increased strategic focus on private payors.

In addition, Spire announced an 18-month extension to the maturity of its existing banking facilities of GBP425 million to August 2028 at unchanged terms.

The facility still comprises a term loan of GBP325 million and a GBP100 million revolving credit facility with the same syndicate of lenders.

Spire said its transformation programme is on track to deliver GBP30 million of new savings during the financial year, with more savings to come in 2026.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Spire Healthcare

Shares in this article

Related News

WINNERS & LOSERS: Energy stocks rise with oil; Renishaw ups guidance
20 Apr 2026

WINNERS & LOSERS: Energy stocks rise with oil; Renishaw ups guidance

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

Risers and Fallers BP + 19 more shares
WINNERS & LOSERS: Goodwin mulls payout policy rethink; oil majors fall
23 Mar 2026

WINNERS & LOSERS: Goodwin mulls payout policy rethink; oil majors fall

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.